More studies are needed to clarify how Notch 3 participates in hematological malignancy pathogenesis, while the lack of compelling data on Notch 4 possibly means a less direct or a non-canonical involvement in leukemia and lymphoma. This evidence concerns the gene NOTCH3 and leukemia.